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Abstract: A new, highly efficient Lewis base catalyst for a practical 
enantio- and diastereoselective crotylation of unsaturated aldehydes 
with E- and Z-crotyltrichlorosilanes has been developed. The method 
was employed as a key step in a novel asymmetric synthesis of 
bioactive serrulatane diterpene (–)-elisabethadione. Other strategic 
reactions for setting up the stereogenic centers included anionic oxy-
Cope rearrangement and cationic cyclization. The synthetic route 
relies on simple, high yielding reactions and avoids use of protecting 
groups or chiral auxiliaries. 
Secondary metabolites isolated from marine soft coral 
Pseudopterogorgia elisabethae exhibit a wide range of useful 
biological properties, which include anti-tubercular, anti-
inflammatory, antimicrobial and cytotoxic activities,[1] while 
partially purified gorgonian extracts are used in commercial skin 
care products.[2] Selected representatives (1-4) of this family of 
marine natural products are shown in Figure 1. 
Potent biological activity and the relatively simple structures of 
serrulatane diterpenes 1, 2 and other analogues, augmented by 
the low abundance and scarcity of supply of these compounds 
from their natural sources, make them attractive synthetic 
targets for exploring their therapeutic potential.[3-6] However, the 
lack of functional groups near the stereogenic centres 
represents a significant challenge for stereoselective synthesis. 
 
Figure 1. Selected Pseudopterogorgia elisabethae secondary metabolites. 
Our novel, general strategy for setting up the stereogenic 
centers at C-1, C-4 and C-11 of the serrulatane skeleton relies 
on enantioselective crotylation of aldehyde 8 to give syn-alcohol 
7 followed by stereoselective anionic oxy-Cope rearrangement 
(AOC)[7] and ensuing cationic cyclization[8] (Scheme 1). 
Importantly, the α-methyl of the cinnamyl fragment and the syn 
configuration of the homoallylic alcohol 7 play a crucial role in 
assuring an efficient transfer of chirality during the AOC 
rearrangement. Of the two possible chair-like transition 
structures A and B, the TS B is disfavored due to the 1,3-
pseudoaxial clash. Additionally, the TS A results in E alkene 6, 
which keys in a formal 6-endo cyclization to afford the desired 
1,4-trans tetralin 5, as shown by Casey and co-workers.[8c]. 
 
Scheme 1. Retrosynthetic analysis of serrulatane diterpenes.  
The success of the strategy relies on the crotylation step (8 → 7, 
Scheme 1), by which chirality is introduced into the molecule. 
Herein, we present development of an efficient, practical and 
scalable method for catalytic asymmetric crotylation of 
unsaturated aldehydes, which is then successfully applied in the 
enantioselective total synthesis of serrulatane diterpene 2 from 
the respective α-methyl cinnamaldehyde 8 (Scheme 1).  
Despite recent advances in the development of catalytic 
asymmetric allylation of carbonyl compounds with B- and Si-
based allyl reagents,[9] including contribution from our group,[10] 
the related crotylation methodology remains a challenging 
problem and is still dominated by stoichiometric chiral B[11] and 
Si[12] reagents. The elegant catalytic method for crotylation of 
aldehydes or alcohols with butadiene reported by Krische[13] 
looks appealing but it does not match the enantio- and 
distereoselectivity level shown by the Type I boron and silicon 
reagents.[14] Brønsted acid catalyzed addition of commercial E- 
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and Z-crotylboronates to aldehydes represented a viable 
option,[15] however due to their relatively high cost and 
uninspiring preliminary attempts[16] our focus centered on a 
Lewis base catalyzed addition of easy to synthesize 
crotyltrichlorosilanes Z-9a and E-9b to unsaturated aldehydes.[17]  
It is well documented that chiral bipyridine-N,N’-dioxides are 
highly efficient catalysts for asymmetric allylation of aldehydes 
with allyltrichlorosilanes.[18] However, none of these catalysts are 
commercially available and their syntheses either involve 
lengthy sequences or give low overall yield, which makes them 
unsuitable for larger scale applications. Therefore, we now 
designed a new axially chiral bis-N-oxide 10 that can be 
synthesized in just 4 easy steps from inexpensive starting 
materials (Scheme 2).  
Synthesis of 10 commenced with preparation of the Kröhnke salt 
12 by iodination of ketone 11 in pyridine (yield 73%).[10g] Kröhnke 
annulation of 12 with commercial (R)-myrtenal 13 in formamide 
in the presence of AcONH4 produced isoquinoline 14 (yield 76%), 
which was converted to the respective N-oxide 15 by treatment 
with mCPBA (yield 94%). In the final step, an oxidative 
coupling[19] of 15 produced (−)-10 as a single distereoisomer. 
Using 1 equiv. of LDA, 10 was commonly isolated in 30-35% 
yield together with ~50% of the unreacted 15. Thus, based on 
the recovered starting material, the yield of 10 in this protocol is 
60-70%. The absolute configuration of the catalyst has not been 
rigorously established but assumed to be as shown in Scheme 2 
by comparison with literature data.[18h] For the new catalysts 10, 
we propose the acronym MAKDIOX (includes initials of the co-
author who developed its synthesis). 
 
Scheme 2. Synthesis of (−)-10 (Ar = 3,5-(CF3)2-C6H3). 
The efficacy of the new catalyst 10 was assessed in the 
asymmetric crotylation of model aldehydes 16a-f with 
crotyltrichlorosilanes Z-9a and E-9b (Table 1). Bis-N-oxide 10 
turned out to be an extremely efficient catalyst producing 
excellent enantio- and diastereoselectivities over a whole range 
of aldehydes tested. Brief screening of solvents identified 
dichloromethane as the optimal choice; propionitrile came close 
second, while THF gave only modest enantioselectivities. 
Catalysts 10 proved particularly efficient with unsaturated 
aldehydes 16d-f (entries 7-14), though with aliphatic 16g 
enantioselectivity dropped (entry 15) representing a common 
trend in the catalytic allylation with allyltrichlorosilanes.[18] 
Diastereoselectivity generally reflected the geometrical purity of 
the starting crotyltrichlorosilanes Z-9a (Z/E 98:2) and E-9b (E/Z 
95:5). However, in propionitrile cinnamyl aldehydes 16d and 16e 
appeared to react slightly faster with Z-9a giving the syn-
enriched alcohols 17d and 17e, respectively (entries 8, 11).  
 
Table 1. Catalytic asymmetric crotylation of aldehydes.[a] 
 
Entry 16 9a/9b Solvent Yield (%)d 17/18 (%)[b] ee (%)[c] 
1 16a 9a DCM 94 98:2 92 
2 16a 9b DCM 91 4:96 96 
3 16b  9a DCM 86 98:2 92 
4 16b  9b DCM 81 4:96 96 
5 16c 9a DCM 93 95:5 85 
6 16c 9b DCM 89 5:95 91 
7 16d 9a DCM 83 98:2 95 
8 16d 9a EtCN 83 99:1 94 
9 16d 9b DCM 89 5:95 98 
10 16e 9a DCM 92 98:2 98 
11 16e 9a EtCN 92 99:1 97 
12 16e 9b DCM 88 3:97 99 
13 16f 9a DCM 80 98:2 98 
14 16f 9b DCM 82 4:96 96 
15 16g 9b DCM 55 4:96 50 
16 16h 9a EtCN 85 99:1 97 
17[d] 16h 9a EtCN 82 99:1 94 
[a] Unless stated otherwise, the reactions were carried out on a 0.5 mmol scale 
at –60 oC for 24 h with 2 mol% loading of (−)-10, 1.7 eq of Z-9a (Z/E 98:2) or E-
9b (E/Z 95:5) and 2.0 eq of iPr2EtN; [b] determined by 1H NMR or GC from the 
crude mixture; [c] ee of the major isomer, the absolute configuration is (1R,2S) 
for 17 and (1R,2R) for 18 ( see Supporting Information); [d] the reaction was 
carried out on a 5 mmol scale, for 48 h. 
Therefore, the asymmetric allylation of aldehyde 16h required 
for the total synthesis of 2 with Z-9a was carried out in 
propionitrile. At 0.5 mmol scale the reaction afforded syn-
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homoallylic alcohol 17h in 85% yield and 97% ee (entry 16). 
Importantly, applying the same reaction conditions to a larger 5 
mmol scale, excellent yield and enantioselectivity retained (yield 
82%, ee 94%, entry 17) paving the way for the asymmetric 
synthesis of 2.  
To progress with the total synthesis, enantiopure alcohol (–)-17h 
was subjected to the AOC rearrangement using excess KH and 
1 equiv. of 18-crown-6 in DME at 40 °C for 5 h (Scheme 3). 
Stereogenic center C-4 in 20 is created during the 
rearrangement, whereas C-11 is formed upon protonation of 
enolate 19.[20] After a brief optimization of the quenching 
conditions, the best results were achieved by cooling the 
reaction mixture to −78 °C, followed by a quick addition of MeOH. 
In this way, 20 was obtained with dr 3:1. To minimize 
manipulation of the oxidation-prone aldehyde and to avoid 
epimerization at C-11, crude 20 was subjected to 
Horner−Wadsworth−Emmons alkenylation conditions[21] using 
phosphonate 21. The corresponding α,β-unsaturated ester 22 
was obtained in 84% yield over 2 steps (dr 3:1). The 
diastereoisomers were not separable at this stage and the 
synthesis was continued with the mixture. 
The final stereogenic centre C-1 was installed through the 
cationic cyclization of 22 upon treatment with MeSO3H to afford 
the tetralin derivative 23 (Scheme 4). Importantly, the reaction 
proceeded with high stereoselectivity giving only the trans 
isomer (dr > 25:1) in 84% yield, as evidenced by 1H NMR 
spectroscopy. 
 
Scheme 3. Anionic oxy-Cope rearrangement of (−)-17g. 
Next, hydrogenation of the double bond in 23 using H-Cube 
(10% Pd/C) followed by reduction of the ester with DIBAL-H 
afforded primary alcohol 24 as a 3:1 mixture of C-11 isomers in 
84% overall yield. At this point, the isomers showed slightly 
different Rf values on TLC but gave a clear baseline separation 
on an analytical HPLC column. Therefore, separation of 500 mg 
of the mixture was successfully accomplished by preparative 
HPLC to furnish pure (−)-24 (dr 20:1). Since this intermediate 
was employed by Davies and co-workers[4,5g] in their synthesis of 
compounds 2-4, it marks the formal total syntheses of all these 
secondary metabolites.[22]  
To complete the synthesis of (−)-2, alcohol (−)-24 was oxidized 
to the respective aldehyde using Dess−Martin periodinane 
(DMP) followed by Wittig alkenylation to afford (−)-25. Next, as a 
possible shortcut to (−)-elisabethadione 2, a one-pot sequence 
involving demethylation of (−)-25 with BBr3 followed by aerobic 
oxidation was examined.[8e] A clean demethylation did take place 
but it was accompanied by hydrobromination of the double bond. 
All attempts to eliminate HBr from this product led to extensive 
decomposition. 
 
Scheme 4. Completion of the total synthesis of (-)-elisabethadione 2. 
Therefore, the synthesis continued along the route described by 
Davies.[4] Partial deprotection of (−)-25 using EtSLi yielded the 
corresponding bisphenol 26 in 68% yield. Importantly, in the 
racemic variant of the synthesis, compound 26, obtained as a 
2:1 mixture of isomers, gave crystals suitable for X-ray 
crystallographic analysis,[23] which confirmed the assigned 
relative configuration of the major isomer (Figure 2) and also 
showed that the two isomers differ only by the configuration at 
C-11.  
 
Figure 2. Crystal structure of 26 and epi-26 highlighting relative 
stereochemistry. The isomers differ only by the position of C(18) and H(11) on 
C(11), manifested by disorder at C(11). 
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In the endgame, bisphenol 26 was first oxidized to the 
respective ortho-quinone by CAN, followed by treatment with 
TsOH in benzene to afford (−)-elisabethadione 2 (dr 20:1, 20% 
yield from alcohol (−)-24), the enantiomer of the natural product. 
The synthesized compound exhibited [α]D = –267 (c 0.16, 
CHCl3), opposite in sign but closely matching the absolute value 
reported by Davies: [α]D =  +278 (c 0.58, CHCl3).[4] Other 
spectral data were also identical to those reported in literature.[4] 
In conclusion, we developed a new bis-N-oxide catalyst for a 
scalable, highly enantioselective crotylation of unsaturated 
aldehydes with E- and Z-crotyltrichlorosilanes. Salient features 
of the new catalyst are: (i) the synthesis involves four easy steps 
from inexpensive, commercially available starting materials and 
is amendable to scale up; (ii) the new protocol is highly 
stereoselective and does not require chiral resolution or 
separation of diastereoisomers. The enantioselective crotylation 
method plays a pivotal role in a novel strategy for assembling 
the structural core of serrulatane diterpenes, which was 
illustrated by the asymmetric total synthesis of ent-
elisabethadione 2, a member of the Pseudopterogorgia 
elisabethae family of bioactive marine natural products. Other 
key steps to install the challenging stereogenic centers include 
anionic oxy-Cope rearrangement and cationic cyclization. The 
synthetic route relies on simple, high yielding reactions and 
avoids use of protecting groups or chiral auxiliaries. A more 
detailed investigation into the scope of the catalytic asymmetric 
crotylation and development of new synthetic applications are 
currently underway. 
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